Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
Balancing Radiation Intensification and Quality of Life in Higher-Risk Prostate Cancer (The BALANCE-RT Trial)
The purpose of the study is to explore the best ways of giving radiation therapy to balance cancer control and treatment side effects.
Prostate Cancer PatientsNon-metastatic Prostate CancerHigh Risk Prostate Cancer
Estimated
~$10 – $6,250
Memorial Sloan Kettering Cancer CenterNCT07751159
Phase 2
Androgen-responsive POSLUMA-guided Intra-prostatic Boost (ARPEGGIO)
This research study is for men with intermediate- or high-risk prostate cancer who are planning to receive hormone therapy and radiation treatment. The purpose…
Intermediate Risk Prostate CancerHigh Risk Prostate CancerProstate Cancer
Estimated
~$10 – $7,500
Martin T. King, MD, PhDNCT07393867